FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997157975> ?p ?o ?g. }

• W2997157975 endingPage "17" @default.
• W2997157975 startingPage "10" @default.
• W2997157975 abstract "Digitalis glycosides exert a positive inotropic effect, i.e. an increase in myocardial contractility associated with a prolongation of relaxation period, and glycosides lower the heart rate (negative chronotropic), impede stimulus conduction (negative dromotropic) and promote myocardial excitability (positive bathmotropic). They seem to influence the activities of both the vagal and the sympathetic systems. Digitalis glycosides that belong to different substance classes are closely comparable concerning pharmacodynamics but differ substantially in regard to pharmacokinetics. Digoxin and its derivatives are less lipophilic, show lower protein binding and shorter half‐life, are mainly eliminated via the kidney and accumulate rather rapidly in cases of insufficient kidney function. Digitoxin is highly lipophilic and extensively bound to plasma proteins, has a longer half‐life, is mainly eliminated in the metabolized state via urine and faeces and does not accumulate in kidney dysfunction. As a result of a more stable pharmacokinetic profile, the incidence of toxic side effects seems to be lower with digitoxin than with digoxin. Since the beginning of the 1990s, the antagonists of the RAAS qualified as the standard treatment for congestive heart failure, often in combination with diuretics, vasodilators or β‐antagonists. However, the important role of digitalis glycosides as therapeutic comedication or alternative was never denied, especially in atrial fibrillation with tachycardia. The PROVED and RADIANCE trials proved a detrimental effect of the withdrawal of digoxin therapy on exercise capacity, left‐ventricular ejection fraction and clinical symptoms. The DIG trial revealed that digoxin comedication in sinus rhythm patients with congestive heart failure was associated with a lower morbidity (as taken from death or hospitalization because of worsening heart failure) and an unchanged overall mortality – being a unique feature among the available inotropic drugs. Comparable studies for digitoxin have not yet been performed but, because of its higher pharmacological stability, it might well be associated with even more advantages in this regard than digoxin." @default.
• W2997157975 created "2020-01-10" @default.
• W2997157975 creator A5019610353 @default.
• W2997157975 creator A5046134265 @default.
• W2997157975 creator A5088871428 @default.
• W2997157975 date "2001-04-01" @default.
• W2997157975 modified "2023-10-18" @default.
• W2997157975 title "Treatment of congestive heart failure - current status of use of digitoxin" @default.
• W2997157975 cites W1547584400 @default.
• W2997157975 cites W165427017 @default.
• W2997157975 cites W1911571046 @default.
• W2997157975 cites W1963719703 @default.
• W2997157975 cites W1967948278 @default.
• W2997157975 cites W1972241980 @default.
• W2997157975 cites W1975569621 @default.
• W2997157975 cites W1976108285 @default.
• W2997157975 cites W1978662036 @default.
• W2997157975 cites W1979344322 @default.
• W2997157975 cites W1982896759 @default.
• W2997157975 cites W1993962625 @default.
• W2997157975 cites W1996877405 @default.
• W2997157975 cites W2002666973 @default.
• W2997157975 cites W2006361537 @default.
• W2997157975 cites W2009847767 @default.
• W2997157975 cites W2014888601 @default.
• W2997157975 cites W2018879787 @default.
• W2997157975 cites W2023224574 @default.
• W2997157975 cites W2035563311 @default.
• W2997157975 cites W2036147767 @default.
• W2997157975 cites W2036414876 @default.
• W2997157975 cites W2045341488 @default.
• W2997157975 cites W2045997014 @default.
• W2997157975 cites W2049083699 @default.
• W2997157975 cites W2050109882 @default.
• W2997157975 cites W2056668107 @default.
• W2997157975 cites W2059697928 @default.
• W2997157975 cites W2066224202 @default.
• W2997157975 cites W2069114074 @default.
• W2997157975 cites W2086158842 @default.
• W2997157975 cites W2097905077 @default.
• W2997157975 cites W2137159337 @default.
• W2997157975 cites W2140554968 @default.
• W2997157975 cites W2154100268 @default.
• W2997157975 cites W2222279575 @default.
• W2997157975 cites W2225157161 @default.
• W2997157975 cites W2272401518 @default.
• W2997157975 cites W2319534362 @default.
• W2997157975 cites W2330699098 @default.
• W2997157975 cites W2411312862 @default.
• W2997157975 cites W2416796951 @default.
• W2997157975 cites W2945068164 @default.
• W2997157975 cites W4210280888 @default.
• W2997157975 cites W4214848213 @default.
• W2997157975 cites W4247115498 @default.
• W2997157975 doi "https://doi.org/10.1111/j.1365-2362.2001.00012.x" @default.
• W2997157975 hasPublicationYear "2001" @default.
• W2997157975 type Work @default.
• W2997157975 sameAs 2997157975 @default.
• W2997157975 citedByCount "5" @default.
• W2997157975 countsByYear W29971579752019 @default.
• W2997157975 countsByYear W29971579752020 @default.
• W2997157975 countsByYear W29971579752022 @default.
• W2997157975 countsByYear W29971579752023 @default.
• W2997157975 crossrefType "journal-article" @default.
• W2997157975 hasAuthorship W2997157975A5019610353 @default.
• W2997157975 hasAuthorship W2997157975A5046134265 @default.
• W2997157975 hasAuthorship W2997157975A5088871428 @default.
• W2997157975 hasConcept C112705442 @default.
• W2997157975 hasConcept C126322002 @default.
• W2997157975 hasConcept C155710745 @default.
• W2997157975 hasConcept C158328960 @default.
• W2997157975 hasConcept C164705383 @default.
• W2997157975 hasConcept C2776445394 @default.
• W2997157975 hasConcept C2777707475 @default.
• W2997157975 hasConcept C2777953023 @default.
• W2997157975 hasConcept C2778198053 @default.
• W2997157975 hasConcept C2779161974 @default.
• W2997157975 hasConcept C2780628665 @default.
• W2997157975 hasConcept C39133596 @default.
• W2997157975 hasConcept C71924100 @default.
• W2997157975 hasConcept C84393581 @default.
• W2997157975 hasConcept C98274493 @default.
• W2997157975 hasConceptScore W2997157975C112705442 @default.
• W2997157975 hasConceptScore W2997157975C126322002 @default.
• W2997157975 hasConceptScore W2997157975C155710745 @default.
• W2997157975 hasConceptScore W2997157975C158328960 @default.
• W2997157975 hasConceptScore W2997157975C164705383 @default.
• W2997157975 hasConceptScore W2997157975C2776445394 @default.
• W2997157975 hasConceptScore W2997157975C2777707475 @default.
• W2997157975 hasConceptScore W2997157975C2777953023 @default.
• W2997157975 hasConceptScore W2997157975C2778198053 @default.
• W2997157975 hasConceptScore W2997157975C2779161974 @default.
• W2997157975 hasConceptScore W2997157975C2780628665 @default.
• W2997157975 hasConceptScore W2997157975C39133596 @default.
• W2997157975 hasConceptScore W2997157975C71924100 @default.
• W2997157975 hasConceptScore W2997157975C84393581 @default.
• W2997157975 hasConceptScore W2997157975C98274493 @default.
• W2997157975 hasIssue "S2" @default.

• next